These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3664494)

  • 1. Effects of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues on DNA in HT-29 human colon carcinoma cells.
    Jesson MI; Johnston JB; Anhalt CD; Begleiter A
    Cancer Res; 1987 Nov; 47(22):5935-8. PubMed ID: 3664494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the DNA-DNA cross-linking activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin.
    Jesson MI; Johnston JB; Robotham E; Begleiter A
    Cancer Res; 1989 Dec; 49(24 Pt 1):7031-6. PubMed ID: 2531036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular pharmacology of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues in human colon carcinoma HT-29 cells in vitro.
    Johnston JB; Pugh L; Begleiter A
    Cancer Res; 1987 Aug; 47(15):4076-80. PubMed ID: 3300958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.
    Wassermann K; Zwelling LA; Mullins TD; Silberman LE; Andersson BS; Bakic M; Acton EM; Newman RA
    Cancer Res; 1986 Aug; 46(8):4041-6. PubMed ID: 3731072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in sensitive and resistant L5178Y lymphoblasts in vitro.
    Begleiter A; Leith MK; Johnston JB
    Cancer Res; 1994 Jan; 54(2):482-6. PubMed ID: 8275485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA crosslinking by 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in HT-29 human colon carcinoma cells in vitro.
    Begleiter A; Johnston JB
    Biochem Biophys Res Commun; 1985 Aug; 131(1):336-8. PubMed ID: 4038300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and binding of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and 3'-(4-morpholinyl)-3'-deaminoadriamycin in L5178Y lymphoblasts in vitro.
    Begleiter A; Jesson MI; Johnston JB
    Cancer Commun; 1990; 2(1):7-12. PubMed ID: 2196074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of DNA damage and cytotoxicity induced in two human colon carcinoma cell lines by cyclodisone.
    Gibson NW
    Cancer Res; 1989 Jan; 49(1):154-7. PubMed ID: 2908842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage and cytotoxicity of 2-chloroethyl (methylsulfonyl)methanesulfonate (NSC 338947) produced in human colon carcinoma cells with or without methylating agent pretreatment.
    Hartley JA; Gibson NW
    Cancer Res; 1986 Aug; 46(8):3871-5. PubMed ID: 3015378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts.
    Begleiter A; Blair GW
    Cancer Res; 1984 Jan; 44(1):78-82. PubMed ID: 6537800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic aspects of DNA damage by morpholinyl and cyanomorpholinyl anthracyclines.
    Westendorf J; Aydin M; Groth G; Weller O; Marquardt H
    Cancer Res; 1989 Oct; 49(19):5262-6. PubMed ID: 2766295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
    Szmigiero L; Erickson LC; Ewig RA; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cytotoxicity and DNA-damaging effects produced in human cells of the Mer+ and Mer- phenotypes by a series of 1-aryl-3-alkyltriazenes.
    Gibson NW; Hartley JA; LaFrance RJ; Vaughan K
    Cancer Res; 1986 Oct; 46(10):4999-5003. PubMed ID: 3756860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
    Szmigiero L; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
    Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA breakage, cytotoxicity, drug accumulation and retention in two human ovarian tumor cell lines AZ224 and AZ364 treated with adriamycin, modulated by verapamil.
    Delvaeye M; Verovski V; De Neve W; Storme G
    Anticancer Res; 1993; 13(5A):1533-8. PubMed ID: 8239532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.
    De Graff WG; Myers LS; Mitchell JB; Hahn SM
    Int J Oncol; 2003 Jul; 23(1):159-63. PubMed ID: 12792789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.